SC 13D Filing

Company

Design Therapeutics, Inc.

Filed

March 31, 2022

Accession Number

0000935836-22-000298

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →